Exposure to green spaces, cardiovascular risk biomarkers and incident cardiovascular disease in older adults: The Seniors-Enrica II cohort

Exposure to green spaces, cardiovascular risk biomarkers and incident cardiovascular disease in older adults: The Seniors-Enrica II cohort

Introduction: The impact of residential green spaces on cardiovascular health in older adults remains uncertain. Methods: Cohort study involving 2114 adults aged ≥ 65 years without cardiovascular disease (CVD), residing in five dense municipalities (Prince et al., 2015) of the Madrid region and with...

Full description

Bibliographic Details
Main Authors:	Cara Scheer, Elena Plans-Beriso, Roberto Pastor-Barriuso, Rosario Ortolá, Mercedes Sotos-Prieto, Verónica Cabañas-Sánchez, Pedro Gullón, Carlos Ojeda Sánchez, Rebeca Ramis, Pablo Fernández-Navarro, Fernando Rodríguez-Artalejo, Esther García-Esquinas
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Environment International
Subjects:	NDVI proBNP hs-TnT IL6 GDF-15 Cardiovascular incidence
Online Access:	http://www.sciencedirect.com/science/article/pii/S0160412024001569

Similar Items

Device-measured movement behaviors and cardiac biomarkers in older adults without major cardiovascular disease: the Seniors-ENRICA-2 study
by: Blanca Fabre-Estremera, et al.
Published: (2023-03-01)

Modern biomarkers in cardiology
by: O. V. Dymova
Published: (2018-09-01)

Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study
by: Kundan Chufal, et al.
Published: (2024-04-01)

The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19
by: Bert Zwaenepoel, et al.
Published: (2021-11-01)

Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients
by: Chen JR, et al.
Published: (2018-12-01)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)

Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis
by: Birutė Gumauskienė, et al.
Published: (2018-09-01)

Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy
by: Madalina Nicoleta Nan, et al.
Published: (2023-04-01)

The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis
by: Susana Coimbra, et al.
Published: (2023-03-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

The Effect of Synbiotic Consumption on Serum NTproBNP, hsCRP and Blood Pressure in Patients With Chronic Heart Failure: A Randomized, Triple-Blind, Controlled Trial
by: Shakiba Shoaei Matin, et al.
Published: (2022-04-01)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction
by: Ye-Xuan Cao, et al.
Published: (2022-02-01)

Cardiovascular abnormalities in dogs with acute pancreatitis
by: Harry Cridge, et al.
Published: (2023-01-01)

The role of exercise training on cardiovascular peptides in patients with heart failure: A systematic review and meta-analysis
by: Abbas Malandish, et al.
Published: (2022-01-01)

Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity
by: Gehan H. AboEl-Magd, et al.
Published: (2017-01-01)

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
by: Luis M. Blanco-Colio, et al.
Published: (2021-03-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Evaluación de biomarcadores cardiopulmonares durante diferentes etapas de Leishmaniasis visceral canina
by: Balikci Canberh, et al.
Published: (2018-01-01)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
by: Michael Fang, et al.
Published: (2023-06-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

ProBNP for stratifying patients with heart failure
by: Antonio Carlos Pereira-Barretto, et al.
Published: (2003-09-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
by: Vasile Foris, et al.
Published: (2023-01-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
by: Felix Hofer, et al.
Published: (2022-08-01)

Acute Responses of Cardiac Biomarkers to Intermittent and Continuous Exercise Are Related to Age Difference but Not I/D Polymorphism in the ACE Gene
by: Akram Falahati, et al.
Published: (2020-07-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls
by: Ana Merino-Merino, et al.
Published: (2022-08-01)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure
by: Lara Aguilar-Iglesias, et al.
Published: (2022-02-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care
by: Bergenzaun Lill, et al.
Published: (2012-09-01)

Urinary N-terminal pro–B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study
by: Keisuke Yamasaki, et al.
Published: (2021-04-01)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
by: Young-Ki Lee, et al.
Published: (2021-07-01)

B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
by: Renato de Falco, et al.
Published: (2021-06-01)